미국의 혈관 접근 기기 시장 규모는 예측 기간인 2025-2032년 동안 5.59%의 CAGR로 2024년 18억 2,275만 달러에서 2032년 28억 2,064만 달러로 성장할 것으로 예상됩니다. 암, 신부전, 당뇨병과 같은 만성질환의 유병률 증가로 인해 빈번한 혈관중재술이 필요하게 됩니다. 항감염 카테터 및 압력 모니터링 카테터 개발을 포함한 기술 발전은 환자의 안전과 시술 효율을 크게 향상시킬 것입니다. 또한, 외래 치료에 대한 선호도가 높아지고 외래 수술 센터가 확대됨에 따라 고급 혈관 접근 솔루션에 대한 수요가 증가하고 있습니다.
예를 들어, Becton Dickinson and Company(BD)는 2024년 10월 BD EZI-O 복강 내 혈관 접근 시스템을 출시했습니다. 이 최첨단 도구는 중환자에게 응급 상황에서 신속한 혈관 접근을 제공합니다. 긴급한 의료 수요에 대응하기 위해 고안된 이 기술은 골수를 통해 수분과 약물을 신속하고 효과적으로 공급할 수 있습니다. 이 혁신의 목적은 특히 쇼크, 심장마비, 외상과 같은 어려운 상황에서 치료의 질을 향상시키는 것입니다.
미국 내 입원율 증가와 만성질환 부담의 증가
미국에서는 암, 심혈관질환, 당뇨병, 만성신장질환 등 만성질환의 확산이 혈관접근장치의 수요를 크게 견인하고 있습니다. 인구 고령화와 생활습관병의 증가에 따라 장기적인 투석, 투석, 화학요법을 필요로 하는 환자의 수가 꾸준히 증가하고 있습니다. 이러한 치료는 일반적으로 혈류에 대한 빈번한 또는 지속적인 접근이 필요하며, 혈관 접근 기기가 필수적입니다. 또한, 수술 및 중증 환자 지원을 위한 입원 및 외래 환자 수가 급증함에 따라 신뢰할 수 있고 효율적인 혈관 접근 솔루션에 대한 수요가 증가하고 있습니다. 미국 의료 시스템이 환자 안전과 카테터 관련 합병증 감소에 초점을 맞추고 있는 가운데, 생체적합성과 감염 예방 기능이 강화된 첨단 혈관 접근 기기의 사용도 증가하고 있습니다. 이는 혈관 접근에 대한 의료계의 광범위한 요구와 환자 관리에서 혈관 접근의 중심적인 역할을 뒷받침합니다. 예를 들어, 2024년 2월 CDC는 미국 성인 약 10명 중 6명이 적어도 한 가지 이상의 만성질환을 앓고 있으며, 10명 중 4명이 두 가지 이상의 만성질환을 앓고 있어 입원 및 장기요양 필요성이 크게 증가하고 있다는 데이터를 발표했습니다.
미국의 혈관 접근 기기 시장에 대해 조사했으며, 시장 개요와 함께 제품 유형별, 용도별, 최종사용자별, 지역별 동향, 시장 진출 기업 프로파일 등의 정보를 전해드립니다.
United States vascular access devices market is projected to witness a CAGR of 5.59% during the forecast period 2025-2032, growing from USD 1,822.75 million in 2024 to USD 2,820.64 million in 2032. The rising prevalence of chronic conditions such as cancer, renal failure, and diabetes requires frequent vascular interventions. Technological advancements, including developing anti-infective and pressure-monitoring catheters, significantly improve patient safety and procedural efficiency. Moreover, the growing preference for outpatient care and the expansion of ambulatory surgical centers are fueling the demand for advanced vascular access solutions.
For instance, Becton, Dickinson and Company (BD) launched the BD EZI-O Intraosseous Vascular Access System in October 2024. This cutting-edge tool offers critical care patients' quick vascular access in emergencies. The technique, which was created to meet urgent medical needs, allows quick and effective delivery of fluids and medications through bone marrow. The goal of the innovation is to improve the quality of care, especially in difficult situations like shock, cardiac arrest, or trauma.
Rising Hospitalization Rates and Increasing Chronic Disease Burden in the U.S.
The growing prevalence of chronic diseases such as cancer, cardiovascular disorders, diabetes, and chronic kidney disease is significantly driving the demand for vascular access devices in the United States. With the aging population and an overall increase in lifestyle-related illnesses, the number of patients requiring long-term intravenous treatments, dialysis, or chemotherapy is rising steadily. These treatments typically involve frequent or continuous access to the bloodstream, making vascular access devices essential. Furthermore, the surge in hospital admissions and outpatient visits for surgical procedures and critical care support enhances the demand for reliable and efficient vascular access solutions. As the U.S. healthcare system continues to shift toward improving patient safety and reducing catheter-related complications, the usage of advanced vascular access devices with enhanced biocompatibility and infection-prevention features is also increasing. This driver underscores the broader healthcare need for vascular access and its central role in patient management. For example, in February 2024, the CDC published data showing that about 6 in 10 adults in the United States have at least one chronic disease, and 4 in 10 have two or more, significantly increasing hospital admissions and long-term care needs.
Technological Advancements in Vascular Access Devices Improve Patient Safety and Outcomes
Continuous innovation in vascular access technologies has been a significant growth factor in the United States market. Manufacturers focus on developing catheters and associated components that minimize the risk of bloodstream infections, thrombosis, and mechanical failures. Advanced coatings such as antimicrobial and antithrombogenic layers, integrated stabilization features, and closed catheter systems are widely used to enhance safety and reduce hospital-acquired infections. In addition, the integration of imaging-guided placement techniques such as ultrasound and real-time catheter tip positioning systems has improved the precision of device insertion and reduced complications. These technologies enhance patient safety and comfort and enable care providers to reduce the overall cost of complications and reductions. The growing demand for devices that support long-term access with minimal interventions is leading hospitals and clinics across the United States. to increasingly adopt next-generation vascular access devices, thereby contributing to overall market growth. Moreover, in July 2023, Access Vascular Inc. announced positive clinical results from its HydroPICC catheter, a peripheral vascular access device that significantly reduced complications like thrombosis and occlusion in a real-world clinical setting.
Peripheral Vascular Access Devices Hold a Significant Market Share
Peripheral vascular access devices represent a significant segment of the United States vascular access devices market, primarily due to their widespread use across multiple clinical applications. These devices are commonly used in inpatient and outpatient settings for short-term therapies such as hydration, medication delivery, and diagnostic testing. Their minimally invasive nature, ease of insertion, and lower complication rates make them a preferred option for emergency care, pediatric treatments, and routine hospital procedures. Midline catheters and peripheral intravenous (PIV) lines have seen increased adoption due to their suitability for intermediate-duration therapies, reducing the need for more invasive central lines. With an increasing number of ambulatory surgeries and a rise in emergency department visits across the United States, peripheral vascular access solutions are in high demand. Their versatility, cost-effectiveness, and growing technological improvements-such as self-sealing valves and securement systems-further accelerate the segment's growth trajectory. In May 2023, Teleflex Incorporated launched the Arrow VPS Rhythm DLX Device, a vascular positioning system with electrocardiogram-based tip confirmation technology, aimed at enhancing precision and patient safety during catheter placements.
Future Market Scenario (2025-2032F)
The United States vascular access devices market is expected to witness robust growth due to rising hospital admissions, the increasing burden of chronic diseases, and technological innovations in catheter materials and placement systems. Growing demand for minimally invasive procedures and enhanced infection prevention measures will also support market expansion. Additionally, supportive reimbursement frameworks and ongoing clinical innovations are likely to create new opportunities across hospitals and ambulatory surgical centers. BD (Becton, Dickinson and Company) introduced the PIVO Pro, a ground-breaking needleless blood collection tool, in November 2023. Upon FDA approval, the device became the first to function smoothly with both integrated and long-term peripheral IV catheters, including the Nexiva system, which now features NearPort IV Access.
Key Players Landscape and Outlook
The key players in the market are significantly investing in the development of vascular access devices and are utilizing strategies such as mergers, acquisitions, partnerships, and new product launches to improve their services and competitiveness. Such efforts will propel significant growth in the market, allowing large-cap industry players to increase their presence and, therefore, find new opportunities in this market.
Mozarc Medical, a joint venture between Medtronic (India Medtronic Private Limited) and DaVita Inc., aimed at promoting advancements in kidney treatment, was established in April 2023. Mozarc wants to improve accessibility and flexibility for people with chronic renal disease by creating home-based and portable dialysis systems. The program demonstrates both businesses' dedication to using technology and patient-centered care to revolutionize kidney health management.
Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.